FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2901934212> ?p ?o ?g. }

• W2901934212 endingPage "719" @default.
• W2901934212 startingPage "712" @default.
• W2901934212 abstract "Declines in percent predicted FVC (% predicted FVC), declines in 6-min walk distance (6MWD), and respiratory hospitalizations are events associated with disease progression and mortality in idiopathic pulmonary fibrosis. The incidence of multiple events in the same patient over 12 months of pirfenidone treatment is unknown.Patients who received pirfenidone 2,403 mg/d (n = 623) or placebo (n = 624) in the ASCEND (study 016; NCT01366209) and CAPACITY (studies 004 and 006; NCT00287716 and NCT00287729) phase III trials were included in this post hoc analysis. Disease progression events were defined as relative decline in % predicted FVC ≥ 10%, absolute decline in 6MWD ≥ 50 m, respiratory hospitalization, or death from any cause. The incidence of disease progression events over 12 months was assessed.The most frequent disease progression events were declines in % predicted FVC (pirfenidone vs placebo; 202 vs 304 events) and declines in 6MWD (pirfenidone vs placebo; 265 vs 348 events). Fewer patients who received pirfenidone had more than one progression event compared with placebo (17.0% vs 30.1%; P < .0001). Death following one or more progression event occurred less frequently in the pirfenidone group than in the placebo group (2.1% vs 6.3%; P = .0002).Pirfenidone significantly reduced the incidence of multiple progression events and death after a progression event over 12 months of treatment compared with placebo. These findings suggest that continued treatment with pirfenidone confers a benefit despite the occurrence of any single disease progression event.ClinicalTrials.gov; Nos. NCT01366209, NCT00287716, and NCT00287729; URL: www.clinicaltrials.gov." @default.
• W2901934212 created "2018-11-29" @default.
• W2901934212 creator A5020873467 @default.
• W2901934212 creator A5030667668 @default.
• W2901934212 creator A5030988190 @default.
• W2901934212 creator A5050993312 @default.
• W2901934212 creator A5052485494 @default.
• W2901934212 creator A5055214457 @default.
• W2901934212 creator A5087322552 @default.
• W2901934212 creator A5088981992 @default.
• W2901934212 creator A5090203143 @default.
• W2901934212 creator A5091330914 @default.
• W2901934212 creator A5091359268 @default.
• W2901934212 date "2019-04-01" @default.
• W2901934212 modified "2023-10-12" @default.
• W2901934212 title "Efficacy of Pirfenidone in the Context of Multiple Disease Progression Events in Patients With Idiopathic Pulmonary Fibrosis" @default.
• W2901934212 cites W1938547050 @default.
• W2901934212 cites W1954728404 @default.
• W2901934212 cites W2053916851 @default.
• W2901934212 cites W2057292199 @default.
• W2901934212 cites W2092648747 @default.
• W2901934212 cites W2100554882 @default.
• W2901934212 cites W2117488044 @default.
• W2901934212 cites W2161655061 @default.
• W2901934212 cites W2167383172 @default.
• W2901934212 cites W2168666423 @default.
• W2901934212 cites W2171738220 @default.
• W2901934212 cites W2208096782 @default.
• W2901934212 cites W2295461102 @default.
• W2901934212 cites W2550523848 @default.
• W2901934212 cites W2604367936 @default.
• W2901934212 cites W2611007056 @default.
• W2901934212 doi "https://doi.org/10.1016/j.chest.2018.11.008" @default.
• W2901934212 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30472023" @default.
• W2901934212 hasPublicationYear "2019" @default.
• W2901934212 type Work @default.
• W2901934212 sameAs 2901934212 @default.
• W2901934212 citedByCount "22" @default.
• W2901934212 countsByYear W29019342122019 @default.
• W2901934212 countsByYear W29019342122020 @default.
• W2901934212 countsByYear W29019342122021 @default.
• W2901934212 countsByYear W29019342122022 @default.
• W2901934212 countsByYear W29019342122023 @default.
• W2901934212 crossrefType "journal-article" @default.
• W2901934212 hasAuthorship W2901934212A5020873467 @default.
• W2901934212 hasAuthorship W2901934212A5030667668 @default.
• W2901934212 hasAuthorship W2901934212A5030988190 @default.
• W2901934212 hasAuthorship W2901934212A5050993312 @default.
• W2901934212 hasAuthorship W2901934212A5052485494 @default.
• W2901934212 hasAuthorship W2901934212A5055214457 @default.
• W2901934212 hasAuthorship W2901934212A5087322552 @default.
• W2901934212 hasAuthorship W2901934212A5088981992 @default.
• W2901934212 hasAuthorship W2901934212A5090203143 @default.
• W2901934212 hasAuthorship W2901934212A5091330914 @default.
• W2901934212 hasAuthorship W2901934212A5091359268 @default.
• W2901934212 hasBestOaLocation W29019342121 @default.
• W2901934212 hasConcept C120665830 @default.
• W2901934212 hasConcept C121332964 @default.
• W2901934212 hasConcept C126322002 @default.
• W2901934212 hasConcept C141071460 @default.
• W2901934212 hasConcept C142724271 @default.
• W2901934212 hasConcept C165637977 @default.
• W2901934212 hasConcept C204787440 @default.
• W2901934212 hasConcept C27081682 @default.
• W2901934212 hasConcept C2777714996 @default.
• W2901934212 hasConcept C2778341716 @default.
• W2901934212 hasConcept C2779832356 @default.
• W2901934212 hasConcept C3018587741 @default.
• W2901934212 hasConcept C55520419 @default.
• W2901934212 hasConcept C61511704 @default.
• W2901934212 hasConcept C71924100 @default.
• W2901934212 hasConceptScore W2901934212C120665830 @default.
• W2901934212 hasConceptScore W2901934212C121332964 @default.
• W2901934212 hasConceptScore W2901934212C126322002 @default.
• W2901934212 hasConceptScore W2901934212C141071460 @default.
• W2901934212 hasConceptScore W2901934212C142724271 @default.
• W2901934212 hasConceptScore W2901934212C165637977 @default.
• W2901934212 hasConceptScore W2901934212C204787440 @default.
• W2901934212 hasConceptScore W2901934212C27081682 @default.
• W2901934212 hasConceptScore W2901934212C2777714996 @default.
• W2901934212 hasConceptScore W2901934212C2778341716 @default.
• W2901934212 hasConceptScore W2901934212C2779832356 @default.
• W2901934212 hasConceptScore W2901934212C3018587741 @default.
• W2901934212 hasConceptScore W2901934212C55520419 @default.
• W2901934212 hasConceptScore W2901934212C61511704 @default.
• W2901934212 hasConceptScore W2901934212C71924100 @default.
• W2901934212 hasFunder F4320309432 @default.
• W2901934212 hasFunder F4320332193 @default.
• W2901934212 hasIssue "4" @default.
• W2901934212 hasLocation W29019342121 @default.
• W2901934212 hasLocation W29019342122 @default.
• W2901934212 hasOpenAccess W2901934212 @default.
• W2901934212 hasPrimaryLocation W29019342121 @default.
• W2901934212 hasRelatedWork W1547683341 @default.
• W2901934212 hasRelatedWork W2108981404 @default.
• W2901934212 hasRelatedWork W2295461102 @default.
• W2901934212 hasRelatedWork W2315538569 @default.
• W2901934212 hasRelatedWork W2411042954 @default.

• next